| Primary |
| Drug Use For Unknown Indication |
59.9% |
| Type 2 Diabetes Mellitus |
9.7% |
| Diabetes Mellitus |
8.7% |
| Product Used For Unknown Indication |
7.7% |
| Hypertension |
1.9% |
| Blood Glucose Increased |
1.4% |
| Diabetes Mellitus Non-insulin-dependent |
1.4% |
| Diabetes Mellitus Inadequate Control |
1.0% |
| Glioblastoma Multiforme |
1.0% |
| Hiv Infection |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Polycystic Ovaries |
1.0% |
| Type 1 Diabetes Mellitus |
1.0% |
| Alcohol Abuse |
0.5% |
| Anticoagulant Therapy |
0.5% |
| Back Pain |
0.5% |
| Diabetes |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Gestational Diabetes |
0.5% |
| Hyperglycaemia |
0.5% |
|
| Death |
49.5% |
| Renal Failure Acute |
8.1% |
| Renal Failure |
7.1% |
| Vomiting |
5.1% |
| Lactic Acidosis |
4.0% |
| Jaundice |
3.0% |
| Myocardial Infarction |
3.0% |
| Cardio-respiratory Arrest |
2.0% |
| Pain |
2.0% |
| Pancreatitis |
2.0% |
| Renal Injury |
2.0% |
| Rhabdomyolysis |
2.0% |
| Shock |
2.0% |
| Vitamin B12 Deficiency |
2.0% |
| Blindness |
1.0% |
| Blood Glucose Decreased |
1.0% |
| Breast Cancer Female |
1.0% |
| Diarrhoea |
1.0% |
| Drug Interaction |
1.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
1.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
68.6% |
| Diabetes Mellitus Non-insulin-dependent |
9.8% |
| Type 2 Diabetes Mellitus |
4.9% |
| Product Used For Unknown Indication |
3.9% |
| Blood Cholesterol Increased |
2.9% |
| Blood Glucose Increased |
2.0% |
| Duodenal Ulcer |
2.0% |
| Anxiety |
1.0% |
| Constipation |
1.0% |
| Depression |
1.0% |
| Hypertension |
1.0% |
| Obsessive-compulsive Disorder |
1.0% |
| Schizophrenia |
1.0% |
|
| Death |
30.6% |
| Blood Glucose Increased |
11.1% |
| Drug Hypersensitivity |
5.6% |
| Pain In Extremity |
5.6% |
| Rash |
5.6% |
| Vomiting |
5.6% |
| Weight Decreased |
5.6% |
| Abdominal Discomfort |
2.8% |
| Abdominal Pain Upper |
2.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.8% |
| Insomnia |
2.8% |
| Multiple Drug Overdose |
2.8% |
| Renal Failure Acute |
2.8% |
| Therapeutic Response Decreased |
2.8% |
| Tremor |
2.8% |
| Vitamin B12 Deficiency |
2.8% |
| Wheezing |
2.8% |
| White Blood Cell Count Increased |
2.8% |
|
| Concomitant |
| Diabetes Mellitus Non-insulin-dependent |
16.7% |
| Product Used For Unknown Indication |
15.6% |
| Diabetes Mellitus |
14.4% |
| Type 2 Diabetes Mellitus |
10.7% |
| Drug Use For Unknown Indication |
8.5% |
| Hypertension |
8.1% |
| Blood Cholesterol Increased |
4.4% |
| Multiple Myeloma |
3.1% |
| Psoriasis |
2.5% |
| Depression |
2.4% |
| Hypothyroidism |
2.3% |
| Polycystic Ovaries |
1.8% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Pain |
1.4% |
| Prophylaxis |
1.3% |
| Rhinitis Allergic |
1.3% |
| Hyperlipidaemia |
1.1% |
| Blood Cholesterol |
1.0% |
| Hypersensitivity |
1.0% |
| Wheezing |
1.0% |
|
| Weight Decreased |
31.9% |
| Myocardial Infarction |
8.4% |
| Vomiting |
8.4% |
| Nausea |
7.2% |
| Blood Glucose Increased |
4.2% |
| Thrombosis |
4.2% |
| Pain |
3.6% |
| Pruritus |
3.6% |
| Drug Ineffective |
3.0% |
| Transient Ischaemic Attack |
3.0% |
| Vision Blurred |
3.0% |
| Weight Increased |
3.0% |
| Breast Cancer |
2.4% |
| Pancreatitis |
2.4% |
| Parathyroid Tumour |
2.4% |
| Cardiac Failure Congestive |
1.8% |
| Hypersomnia |
1.8% |
| Injection Site Haemorrhage |
1.8% |
| Injection Site Rash |
1.8% |
| Injection Site Urticaria |
1.8% |
|
